Valuation : genOway

Market Cap 22.77M 26.43M 21.35M 19.49M 36.72M 2.53B 36.84M 253M 98.84M 1.28B 99.23M 97.07M 4.23B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.49M 34.23M 27.65M 25.24M 47.55M 3.27B 47.7M 328M 128M 1.65B 128M 126M 5.48B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+0.41%
1 week+0.41%
Current month+1.23%
1 month+0.41%
3 months+2.92%
6 months+1.23%
Current year-8.86%
1 week 2.44
Extreme 2.44
2.51
1 month 2.4
Extreme 2.4
2.58
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%+0.41%-17.67%-32.33% 26.43M
-0.78%-1.42%+2.49%+22.78% 50.47B
-6.00%-0.75%+442.41%+544.39% 44.56B
-0.24%+0.74%+38.69%+18.02% 43.08B
-1.55%-2.07%+23.08%+81.47% 41.7B
-0.31%-0.83%+16.15%+51.42% 33.21B
-1.79%-3.24%+27.00%+129.56% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.60%+27.75% 14.58B
-1.66%-1.25%+78.59%+46.66% 13.92B
Average -1.34%-0.91%+69.15%+98.86% 27.46B
Weighted average by Cap. -1.70%-1.06%+95.70%+133.61%

Financials

2024 2025
Net sales 27.53M 31.95M 25.81M 23.56M 44.39M 3.05B 44.53M 306M 119M 1.54B 120M 117M 5.11B 28.6M 33.19M 26.82M 24.48M 46.11M 3.17B 46.26M 318M 124M 1.6B 125M 122M 5.31B
Net income 1.83M 2.12M 1.72M 1.57M 2.95M 203M 2.96M 20.36M 7.95M 102M 7.98M 7.8M 340M 928K 1.08M 870K 794K 1.5M 103M 1.5M 10.32M 4.03M 51.94M 4.04M 3.95M 172M
Net Debt 623K 723K 584K 533K 1M 69.1M 1.01M 6.93M 2.7M 34.88M 2.71M 2.66M 116M 6.72M 7.8M 6.3M 5.75M 10.83M 745M 10.87M 74.73M 29.16M 376M 29.27M 28.63M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-08-28 €2.470 +0.41% 4,008
26-08-27 €2.460 +0.41% 196
26-08-26 €2.450 -0.41% 1,996
26-08-25 €2.460 +0.82% 1,760
26-08-24 €2.440 -0.81% 1,250
  1. Stock Market
  2. Stocks
  3. ALGEN Stock